Literature DB >> 7276463

Abnormal thyroid stimulating hormone following pituitary surgery.

G K Worth, R W Retallack, D H Gutteridge.   

Abstract

Biologically inactive thyroid stimulating hormone (TSH) has been reported in hypothyroid patients. We report the first case of immunoreactive, but abnormal TSH in a euthyroid patient following hypophysectomy for a prolactin secreting pituitary adenoma. Indirect evidence indicates that this abnormal TSH was biologically inactive. The TSH was characterized by gel chromatography and has a molecular weight of approximately 23,000 daltons.

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7276463     DOI： 10.1007/BF03350459

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


  12 in total

1.  Case of hyperthyroidism due to a chromophobe adenoma.

Authors:  P H Baylis
Journal:  Clin Endocrinol (Oxf)       Date:  1976-03       Impact factor: 3.478

2.  Glandular end organ deficiency associated with secretion of biologically inactive pituitary peptides.

Authors:  D T Krieger
Journal:  J Clin Endocrinol Metab       Date:  1974-06       Impact factor: 5.958

3.  Serum thyrotropin (TSH) in pituitary and-or hypothalamic hypothyroidism: normal or elevated basal levels and paradoxical responses to thyrotropin-releasing hormone.

Authors:  Y C Patel; H G Burger
Journal:  J Clin Endocrinol Metab       Date:  1973-08       Impact factor: 5.958

4.  Inhibition of thyrotropin and prolactin secretions in primary hypothyroidism by 2-Br-alpha-ergocryptine.

Authors:  K Miyal; T Onishi; M Hosokawa; K Ishibashi; Y Kumahara
Journal:  J Clin Endocrinol Metab       Date:  1974-08       Impact factor: 5.958

5.  Measurements of the thyroid-stimulating hormone content of serum from hypothyroid and euthyroid people.

Authors:  D D Adams; T H Kennedy
Journal:  J Clin Endocrinol Metab       Date:  1968-03       Impact factor: 5.958

6.  Chromatographic differences between circulating and pituitary thyrotropins.

Authors:  R C Dimond; S W Rosen
Journal:  J Clin Endocrinol Metab       Date:  1974-08       Impact factor: 5.958

7.  Thyrotropin secretion in patients with central hypothyroidism: evidence for reduced biological activity of immunoreactive thyrotropin.

Authors:  G Faglia; L Bitensky; A Pinchera; C Ferrari; A Paracchi; P Beck-Peccoz; B Ambrosi; A Spada
Journal:  J Clin Endocrinol Metab       Date:  1979-06       Impact factor: 5.958

8.  Pituitary hyperthyroidism. Case report and review of the literature.

Authors:  G Tolis; C Bird; G Bertrand; J M McKenzie; C Ezrin
Journal:  Am J Med       Date:  1978-01       Impact factor: 4.965

9.  Recurrent goiter, hyperthyroidism, galactorrhea and amenorrhea due to a thyrotropin and prolactin-producing pituitary tumor.

Authors:  K Horn; F Erhardt; R Fahlbusch; C R Pickardt; K V Werder; P C Scriba
Journal:  J Clin Endocrinol Metab       Date:  1976-07       Impact factor: 5.958

10.  The secretion of thyrotrophin with impaired biological activity in patients with hypothalamic-pituitary disease.

Authors:  V B Petersen; A M McGregor; P E Belchetz; R S Elkeles; R Hall
Journal:  Clin Endocrinol (Oxf)       Date:  1978-05       Impact factor: 3.478
View more
  1 in total

1.  Radioligand receptor assay for TSH and TSH-binding-inhibiting antibodies using solubilized TSH-receptor.

Authors:  P Kotulla; C Kostner; H Schleusener
Journal:  J Endocrinol Invest       Date:  1983-04       Impact factor: 4.256
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.